Infectious Bursal Disease (IBD) Antibodies for Animal Use 250ml/Bottle

• Customization: Available
• Varieties: Infectious Disease Prevention Medicine
• Component: Animal
• Model NO.: Sinder Bursacure
• Pharmacodynamic Influential Factors: Animal Species
• Storage Method: Light Proof
• Veterinary Reg. No.: 150432064
• Main Ingredients: Infectious Bursal Diseases Antibody
• Shelf Life: 18 Months
• Storage: 2-8
• Adverse Effect: None
• Administration: Intramuscular Injection, Subcutaneous Injection
• Transport Package: Box
• Specification: 100ml/bottle, 250ml/bottle, 500ml/bottle
• Trademark: SINDER
• Origin: Zhucheng City, China
• HS Code: 3001909099
• Production Capacity: 100000L/Year
• Package Size: 67.00cm * 40.00cm * 22.00cm
• Package Gross Weight: 13.500kg

Product Description

Sinder Bursacure
(Infectious Bursal Disease Antibodies)

  Please Use under the Guidance of Veterinarian
 (Generic Name)Infectious Bursal Disease Antibodies
 (Trade name)  Sinder Bursacure
 (Main Ingredients)Infectious Bursal Diseases antibody. AGP ≥1:32
 (Properties)This product is a light brown or light yellow transparent liquid. There may be a little white precipitate at bottle bottom if stand it for 48 hours. The pH value is of 6.8-7.2.

(Effect and Usage) This product is used for early and middle stage of infection treatment and urgent prevention of Infectious Bursal Disease (IBD).
(Administration and Dosage)Intramuscular injection, subcutaneous injection or intraperitoneal injection.
For treatment: chickens less than 35-days-old, 2ml each; more than 35-days-old, 3ml each.
For urgent prevention: chickens less than 25-days-old, 1ml each; 25~35-days-old, 1.5ml each; 35~45-days-old, 2ml each; more than 45-days-old, 2.5-4ml each. This product can be used continuously for 2 to 3 times injections if necessary.
(Side Effects)There is no observed adverse effect generally.
(Precautions)
1. The passive immunity protection period by this product for once injection is 5-7 days.
2. This product is not effective by oral application.
3. This product can be administered for multiple injections 2~3 times continuously.
4. This product contains several kind of antibodies against multiple pathogens besides the Infectious Bursal Disease (IBD). It is forbidden to vaccinate IBD, Newcastle Disease (ND) and Infectious Bronchitis (IB) live vaccines, etc in five days after application of this product.
5. The product can be injected together with kanamycin and gentamicin.  
6. There is no influence to therapeutic effect if there is a little white precipitate at bottle bottom for long time storage.
(Specification)100ml/bottle, 250ml/bottle, 500ml/bottle.
(Storage and Validity)Store at 2-8ºC and the validity from the production date is 18 months.
(Drug Approval No.)Shou Yao Sheng Zi (2015)150432064.
(Executive standard)Nong Mu Fa [2000]No.12.
(GMP Certificate No.)(2014) Shou Yao GMP Zheng Zi 143.
(Manufacturer)Shandong Sinder Technology Co., Ltd.
Country of Origin: China

Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.

Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!

Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.

Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.